Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Baerveldt Versus Paul (BvP) Study: a Registry-based Randomised Controlled Trial.

NCT: NCT07733453 · NOT_YET_RECRUITING

NCT IDNCT07733453
StatusNOT_YET_RECRUITING
Start Date2026-10-12
Completion2033-04
SponsorUniversity of Sydney (OTHER)
First posted
Last updated

Brief Summary

The Baerveldt Versus Paul (BvP) Study is a Registry-based Randomised Controlled Trial, Comparing the Baerveldt Glaucoma Implant (BGI) and the Paul Glaucoma Implant (PGI). Participants will Include patients requiring aqueous shunt surgery for control of intraocular pressure and glaucoma. The objective of this study is to compare the long-term safety and effectiveness of placement of a BGI and PGI for patients who are undergoing aqueous shunt implant surgery. Patients who qualify for the study are randomized to receive either a BGI or PGI aqueous shunt.

Frequently Asked Questions

What is The Baerveldt Versus Paul (BvP) Study: a Registry-based Randomised Controlled Trial.?

The Baerveldt Versus Paul (BvP) Study: a Registry-based Randomised Controlled Trial. is a clinical trial registered under NCT07733453. Current status: NOT_YET_RECRUITING.

What is the status of NCT07733453?

The current status of NCT07733453 (The Baerveldt Versus Paul (BvP) Study: a Registry-based Randomised Controlled Trial.) is: NOT_YET_RECRUITING.

When did The Baerveldt Versus Paul (BvP) Study: a Registry-based Randomised Controlled Trial. start?

The Baerveldt Versus Paul (BvP) Study: a Registry-based Randomised Controlled Trial. started on 2026-10-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.